ABIVAX (EPA:ABVX) | Finanzwire

Basculer en Français

10551	Companies
222936	Keywords
152026	Articles
117974	Press releases

Home
Companies
ABIVAX

PRESS RELEASE

published on 05/08/2024 at 08:31, 2 years 1 month ago

Abivax announces presentation of four abstracts for obefazimod in ulcerative colitis and preclinical colon cancer model at Digestive Disease Week 2024
Abivax presents four abstracts on obefazimod for ulcerative colitis and colon cancer model at Digestive Disease Week 2024. The company highlights novel mechanism of action and positive clinical data for obefazimod

Abivax Obefazimod Ulcerative Colitis Digestive Disease Week Colon Cancer
PRESS RELEASE

published on 05/08/2024 at 08:30, 2 years 1 month ago

Abivax announces presentation of four abstracts for obefazimod in ulcerative colitis and preclinical colon cancer model at Digestive Disease Week 2024
Abivax announces presentation of four abstracts for obefazimod in ulcerative colitis and preclinical colon cancer model at Digestive Disease Week 2024. The event will showcase new data on obefazimod's impact and mechanism of action

Abivax Obefazimod Ulcerative Colitis Colon Cancer Digestive Disease Week 2024
BRIEF

published on 05/07/2024 at 22:05, 2 years 1 month ago

Abivax Announces Availability of Documents for Upcoming General Meeting

Biotechnology Shareholder Information Corporate Governance Abivax General Meeting
PRESS RELEASE

published on 05/07/2024 at 22:00, 2 years 1 month ago

Abivax annual ordinary and extraordinary general meeting of May 30, 2024 - Availability of the preparatory documents
Abivax informs shareholders of its ordinary and extraordinary general meeting on May 30, 2024, providing access to preparatory documents and details on participation. Obefazimod and Abivax information included

Abivax Obefazimod General Meeting Clinical-stage Biotechnology Preparatory Documents
PRESS RELEASE

published on 05/07/2024 at 22:00, 2 years 1 month ago

Abivax annual ordinary and extraordinary general meeting of May 30, 2024 - Availability of the preparatory documents
Abivax announces its annual ordinary and extraordinary general meeting on May 30, 2024, with preparatory documents available for shareholders. The meeting details, including agenda and resolutions, are accessible on the company's website

Shareholders Biotechnology Abivax General Meeting Preparatory Documents
BRIEF

published on 04/30/2024 at 18:05, 2 years 1 month ago

ABIVAX reports the number of shares and voting rights as of March 31, 2024

Share Capital Voting Rights Financial Markets Authority Abivax Regulatory Information
BRIEF

published on 04/05/2024 at 22:05, 2 years 2 months ago

Abivax Announces Submission of Financial Reports to French and U.S. Regulatory Agencies

Abivax Financial Reports Chronic Inflammatory Diseases Regulatory Agencies Webcast Announcement
PRESS RELEASE

published on 04/05/2024 at 22:00, 2 years 2 months ago

Abivax publishes financial reports with the French and U.S. securities regulatory agencies
Abivax publishes 2023 financial reports with French and U.S. securities regulators, including annual report and governance information

Abivax Financial Reports Regulatory Agencies French Securities U.S. Securities
BRIEF

published on 04/02/2024 at 08:35, 2 years 2 months ago

Abivax Reports 2023 Financial Results and Operational Update

Financial Results Abivax Obefazimod Ulcerative Colitis Nasdaq IPO
PRESS RELEASE

published on 04/02/2024 at 08:30, 2 years 2 months ago

Abivax reports 2023 financial results and operational update
Abivax reports 2023 financial results & operational update. Raised EUR 500M, aims to finance operations till Q4 2025. Webcast on April 8, 2024

Financial Results Fundraising Abivax Webcast Operational Update

Accesswire

Published on 06/11/2026 at 00:51, 59 minutes ago

Touchstone Exploration Announces Closing of the Fundraise and Notice of AGM
Published on 06/11/2026 at 00:30, 1 hour 20 minutes ago

BioNxt Solutions Inc. Announces Extension of Convertible Debentures and Issuance of Warrants
Published on 06/11/2026 at 00:10, 1 hour 40 minutes ago

Route1 Inc. Adopts Shareholder Rights Plan
Published on 06/10/2026 at 23:05, 2 hours 45 minutes ago

Faraday Copper Announces Annual General Meeting Voting Results
Published on 06/10/2026 at 14:30, 11 hours 20 minutes ago

Agassi Sports Entertainment Signs Tennis Coaching Icon Darren Cahill to Expand Global Coaching, Content and Technology Initiatives

View all ACCESSWIRE

EQS Group

Published on 06/10/2026 at 23:56, 1 hour 54 minutes ago

EQS-Adhoc: HUGO BOSS AG: HUGO BOSS informs about unsolicited voluntary takeover offer by Frasers Group plc
Published on 06/10/2026 at 22:05, 3 hours 45 minutes ago

Ridgewood Infrastructure Acquires Dauntless Air, Premier Provider of Emergency Management Infrastructure
Published on 06/10/2026 at 21:45, 4 hours 5 minutes ago

EQS-Adhoc: MAHLE has successfully priced the issuance of additional EUR 200 million notes due 2032 and is launching a partial tender offer for its outstanding notes due 2028
Published on 06/10/2026 at 20:11, 5 hours 39 minutes ago

EQS-Adhoc: EDAG Engineering Group AG: Board of Directors resolves on capital measures to strengthen capital base
Published on 06/10/2026 at 18:39, 7 hours 11 minutes ago

EQS-Adhoc: Kontron AG: Ad hoc announcement / Ennoconn Corporation intends to launch a mandatory takeover offer to Kontron AG shareholders

Les Echos

Published on 06/10/2026 at 18:29, 7 hours 21 minutes ago

ICADE – PR – OUTCOME OF THE COMBINED GENERAL MEETING HELD ON JUNE 10 2026
Published on 06/10/2026 at 17:59, 7 hours 51 minutes ago

CDA - STGM has received € 127 million
Published on 06/10/2026 at 17:40, 8 hours 10 minutes ago

Report on share repurchases from 3 to 9 June 2026
Published on 06/10/2026 at 07:00, 18 hours 50 minutes ago

Acceleration of Museum Studio's international expansion
Published on 06/09/2026 at 19:30, 1 day 6 hours ago

MONTHLY INFORMATION CONCERNING THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES

View all LES ECHOS COMFI WIRE